EP08.02-162 Tepotinib with an EGFR-Tyrosine Kinase Inhibitor (TKI) in Patients with EGFR-mutant MET-amplified NSCLC: A Case Series
Le, X., Eisert, A., Himpe, U., De Bondt, C., Mazieres, J., Petrini, I., Tho, L.M., Ahmad, A., Lam, W.-S., Chik, Y.K.J., Lee, W.C.K., Yang, T.-Y., Joshi, K., Berghoff, K., Vlassak, S., Karachaliou, N., Wekken, A.v.d.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article